Treatment of severe lichen planus with the JAK inhibitor tofacitinib

被引:50
作者
Damsky, William [1 ]
Wang, Alice [1 ]
Olamiju, Brianna [1 ]
Peterson, Danielle [1 ]
Galan, Anjela [1 ,2 ]
King, Brett [1 ]
机构
[1] Yale Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[2] Yale Sch Med, Dept Pathol, New Haven, CT USA
关键词
D O I
10.1016/j.jaci.2020.01.031
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1708 / +
页数:9
相关论文
共 6 条
[1]   JAK inhibitors in dermatology: The promise of a new drug class [J].
Damsky, William ;
King, Brett A. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) :736-744
[2]   Targeting the IFN-γ/CXCL10 pathway in lichen planus [J].
Di Lernia, Vito .
MEDICAL HYPOTHESES, 2016, 92 :60-61
[3]   A scoring system for mucosal disease severity with special reference to oral lichen planus [J].
Escudier, M. ;
Ahmed, N. ;
Shirlaw, P. ;
Setterfield, J. ;
Tappuni, A. ;
Black, M. M. ;
Challacombe, S. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (04) :765-770
[4]   Clinical epidemiology and treatment of lichen planus: A retrospective review of 2 tertiary care centers [J].
Schwager, Zachary ;
Stern, Marleigh ;
Cohen, Jeffrey ;
Femia, Alisa .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (06) :1397-1399
[5]   IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus [J].
Shao, Shuai ;
Tsoi, Lam C. ;
Sarkar, Mrinal K. ;
Xing, Xianying ;
Xue, Ke ;
Uppala, Ranjitha ;
Berthier, Celine C. ;
Zeng, Chang ;
Patrick, Matthew ;
Billi, Allison C. ;
Fullmer, Joseph ;
Beamer, Maria A. ;
Perez-White, Bethany ;
Getsios, Spiro ;
Schuler, Andrew ;
Voorhees, John J. ;
Choi, Sung ;
Harms, Paul ;
Kahlenberg, J. Michelle ;
Gudjonsson, Johann E. .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (511)
[6]   Tofacitinib for the treatment of lichen planopilaris: A case series [J].
Yang, Christine C. ;
Khanna, Trisha ;
Sallee, Brigitte ;
Christiano, Angela M. ;
Bordone, Lindsey A. .
DERMATOLOGIC THERAPY, 2018, 31 (06)